severe personal injury/loss and damage; spasms; dysautonomia; limb swelling; skin rash; coughing; acquired asthma; joint pains; elevated heart rate; postural tachycardia syndrome; breathlessness; chronic fatigue; effects for mental wellbeing; This is a spontaneous report received from a contactable reporter(s) (Lawyer) from legal division.  A 40-year-old female patient received BNT162b2 (BNT162B2), on 20May2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 40 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INJURY (non-serious), outcome "unknown", described as "severe personal injury/loss and damage"; MUSCLE SPASMS (non-serious), outcome "unknown", described as "spasms"; AUTONOMIC NERVOUS SYSTEM IMBALANCE (non-serious), outcome "unknown", described as "dysautonomia"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "limb swelling"; RASH (non-serious), outcome "unknown", described as "skin rash"; COUGH (non-serious), outcome "unknown", described as "coughing"; ASTHMA (non-serious), outcome "unknown", described as "acquired asthma"; ARTHRALGIA (non-serious), outcome "unknown", described as "joint pains"; HEART RATE INCREASED (non-serious), outcome "unknown", described as "elevated heart rate"; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (non-serious), outcome "unknown", described as "postural tachycardia syndrome"; DYSPNOEA (non-serious), outcome "unknown", described as "breathlessness"; FATIGUE (non-serious), outcome "unknown", described as "chronic fatigue"; EMOTIONAL DISTRESS (non-serious), outcome "unknown", described as "effects for mental wellbeing". The events "severe personal injury/loss and damage", "dysautonomia", "limb swelling", "skin rash", "coughing", "acquired asthma", "joint pains", "elevated heart rate", "postural tachycardia syndrome", "breathlessness", "chronic fatigue" and "effects for mental wellbeing" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information : On 20May2021, an agent of the (Health department withheld) injected Ms. (Name withheld) with a drug approved by the Minister and included in the program, namely BioNTeeh Covid 19 mRNA. In consequence of the said injection, Ms. (Name withheld) proceeded to suffer severe personal injury, loss and damage, including spasms, dysautonomia, limb swelling, skin rash, coughing, acquired asthma, joint pains, elevated heart rate, postural tachycardia syndrome, breathlessness, chronic fatigue, and effects for mental wellbeing. She remains under the care of respiratory doctors and a consultant in infectious diseases. This letter was being sent whilst investigations was on-going, ahead of the issuing of proceedings, to protect the Plaintiff's position. They therefore request that she treat the within requests as a matter of urgency. They believe that the aforesaid injuries were caused and/or materially contributed to by negligence and wrongs on her part- inter alia, in exposing Ms. (Name withheld) to an inappropriate risk of injury, in failing to be sufficiently acquainted with the risks of injury prior to authorizing and administering the said drug, misrepresenting the said drug as a vaccine and not a DNA-altering drug, pressurizing members of the public (including Ms. (Name withheld)) to receive the drug, and failing to warn members of the public (including Ms. (Name withheld)) sufficiently on the known and possible side-effects and risks of injury. They believe further that the above named State and public authorities were liable to the (Withheld) under provisions of (Withheld) for having failed to put in place an appropriate scheme of compensation and support for persons who suffered injury, damage and loss due to having accepted a vaccine that the State and its agents actively encouraged its citizens to take. They therefore call upon her to confirm in an open letter within a period of 14 days from the date hereof her full liability with her proposals to compensate Ms. (Name withheld) fully for all the personal injury, loss and damage which she has been caused to suffer.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.